LMK235, class I and HDAC6-preferential HDAC inhibitor, ameliorated hypertension via inhibition of vascular contraction and vessel hypertrophy in mouse Ang II-infusion model and spontaneously hypertensive rat model (Choi et al. 2019). This evidence concerns the gene HDAC9 and hypertensive disorder.